Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Flomenberg

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Immunologic effects of interleukin 2 in primary immunodeficiency diseasesN Flomenberg, K Welte, R Mertelsmann, et al.
Transplantation Proceedings|December 1, 1987
HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency diseaseR J O'Reilly, C Keever, N A Kernan, et al.
Blood|November 1, 1989
Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplantsN A Kernan, C Bordignon, G Heller, et al.
Blood|November 15, 1995
Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemiaM J Hessner, D J Endean, J T Casper, et al.
The Journal of Infectious Diseases|March 1, 1993
Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivoW R Drobyski, W M Dunne, E M Burd, et al.
Cancer Clinical Trials|January 1, 1981
Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanineZ A Arlin, N Flomenberg, T S Gee, et al.
Human Immunology|January 1, 1986
ASHI Workshop Summary Report of the Science and Education Subcommittee: structural and functional relationships of human class II MHC moleculesD D Eckels, A Zeevi, P G Beatty, et al.
Blood|April 1, 1989
Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow graftsC A Keever, T N Small, N Flomenberg, et al.
Bone Marrow Transplantation|June 1, 1995
Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantationJ Nemunaitis, C S Rosenfeld, R Ash, et al.
Progress in Clinical and Biological Research|January 1, 1992
New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical resultsN H Collins, M H Carabasi, S Bleau, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Immunologic effects of interleukin 2 in primary immunodeficiency diseasesN Flomenberg, K Welte, R Mertelsmann, et al.
Transplantation Proceedings|December 1, 1987
HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency diseaseR J O'Reilly, C Keever, N A Kernan, et al.
Blood|November 1, 1989
Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplantsN A Kernan, C Bordignon, G Heller, et al.
Blood|November 15, 1995
Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemiaM J Hessner, D J Endean, J T Casper, et al.
The Journal of Infectious Diseases|March 1, 1993
Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivoW R Drobyski, W M Dunne, E M Burd, et al.
Cancer Clinical Trials|January 1, 1981
Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanineZ A Arlin, N Flomenberg, T S Gee, et al.
Human Immunology|January 1, 1986
ASHI Workshop Summary Report of the Science and Education Subcommittee: structural and functional relationships of human class II MHC moleculesD D Eckels, A Zeevi, P G Beatty, et al.
Blood|April 1, 1989
Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow graftsC A Keever, T N Small, N Flomenberg, et al.
Bone Marrow Transplantation|June 1, 1995
Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantationJ Nemunaitis, C S Rosenfeld, R Ash, et al.
Progress in Clinical and Biological Research|January 1, 1992
New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical resultsN H Collins, M H Carabasi, S Bleau, et al.
Pageof 10